|
1
|
Leece R, Xu J, Ostrom QT, Chen Y, Kruchko
C and Barnholtz-Sloan JS: Global incidence of malignant brain and
other central nervous system tumors by histology, 2003–2007. Neuro
Oncol. 19:1553–1564. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van Loon EM, Heijenbrok-Kal MH, van Loon
WS, van den Bent MJ, Vincent AJ, de Koning I and Ribbers GM:
Assessment methods and prevalence of cognitive dysfunction in
patients with low-grade glioma: A systematic review. J Rehabil Med.
47:481–488. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gauthier S, Reisberg B, Zaudig M, Petersen
RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D,
Chertkow H, et al International psychogeriatric association expert
conference on mild cognitive impairment, : Mild cognitive
impairment. Lancet. 367:1262–1270. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Derks J, Reijneveld JC and Douw L: Neural
network alterations underlie cognitive deficits in brain tumor
patients. Curr Opin Oncol. 26:627–633. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wärnberg J, Gomez-Martinez S, Romeo J,
Díaz LE and Marcos A: Nutrition, inflammation, and cognitive
function. Ann NY Acad Sci. 1153:164–175. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Markowitz J, MacKerell AD Jr and Weber DJ:
A search for inhibitors of S100B, a member of the S100 family of
calcium-binding proteins. Mini Rev Med Chem. 7:609–616. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nguyen DN, Spapen H, Su F, Schiettecatte
J, Shi L, Hachimi-Idrissi S and Huyghens L: Elevated serum levels
of S-100beta protein and neuron-specific enolase are associated
with brain injury in patients with severe sepsis and septic shock.
Crit Care Med. 34:1967–1974. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nasreddine ZS, Phillips NA, Bédirian V,
Charbonneau S, Whitehead V, Collin I, Cummings JL and Chertkow H:
The Montreal Cognitive Assessment, MoCA: A brief screening tool for
mild cognitive impairment. J Am Geriatr Soc. 53:695–699. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meskal I, Gehring K, van der Linden SD,
Rutten GJ and Sitskoorn MM: Cognitive improvement in meningioma
patients after surgery: clinical relevance of computerized testing.
J Neurooncol. 121:617–625. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Olson RA, Chhanabhai T and McKenzie M:
Feasibility study of the Montreal Cognitive Assessment (MoCA) in
patients with brain metastases. Support Care Cancer. 16:1273–1278.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Boone M, Roussel M, Chauffert B, Le Gars D
and Godefroy O: Prevalence and profile of cognitive impairment in
adult glioma: A sensitivity analysis. J Neurooncol. 129:123–130.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Taphoorn MJ and Klein M: Cognitive
deficits in adult patients with brain tumours. Lancet Neurol.
3:159–168. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Petersen RC, Doody R, Kurz A, Mohs RC,
Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L and Winblad B:
Current concepts in mild cognitive impairment. Arch Neurol.
58:1985–1992. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nasreddine ZS, Phillips NA, Bédirian V,
Charbonneau S, Whitehead V, Collin I, Cummings JL and Chertkow H:
The Montreal Cognitive Assessment, MoCA: A brief screening tool for
mild cognitive impairment. J Am Geriatr Soc. 53:695–699. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chaves ML, Camozzato AL, Ferreira ED,
Piazenski I, Kochhann R, Dall'Igna O, Mazzini GS, Souza DO and
Portela LV: Serum levels of S100B and NSE proteins in Alzheimer's
disease patients. J Neuroinflammation. 7:62010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baune BT, Wiede F, Braun A, Golledge J,
Arolt V and Koerner H: Cognitive dysfunction in mice deficient for
TNF-α and its receptors. Am J Med Genet B Neuropsychiatr Genet
147B. 1056–1064. 2008. View Article : Google Scholar
|
|
18
|
Barone FC, Arvin B, White RF, Miller A,
Webb CL, Willette RN, Lysko PG and Feuerstein GZ: Tumor necrosis
factor-alpha. A mediator of focal ischemic brain injury. Stroke.
28:1233–1244. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weaver JD, Huang MH, Albert M, Harris T,
Rowe JW and Seeman TE: Interleukin-6 and risk of cognitive decline:
MacArthur studies of successful aging. Neurology. 59:371–378. 2002.
View Article : Google Scholar : PubMed/NCBI
|
